Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 15/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | TERT | O14746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29463725 | 1.00 | ACHE (0.55) | ACHECYP1A2CYP2A6TERT | |
| SCHEMBL20425759 | 0.93 | ACHE (0.65) | ACHECYP1A2CYP2A6 | |
| SCHEMBL30362161 | 0.93 | ACHE (0.65) | ACHECYP1A2CYP2A6 | |
| Perchlorate SCHEMBL10009695 | 0.93 | ACHE (0.49) | ACHECYP1A2CYP2A6TERT | |
| Perchlorate SCHEMBL29876325 | 0.93 | ACHE (0.49) | ACHECYP1A2CYP2A6TERT | |
| SCHEMBL3972008 | 0.83 | ACHE (0.74) | ACHE | |
| SCHEMBL29411838 | 0.83 | ACHE (0.74) | ACHE | |
| SCHEMBL18292171 | 0.81 | TERT (0.40) | ACHECYP1A2CYP2A6TERT | |
| SCHEMBL22339074 | 0.80 | ACHE (0.53) | ACHECYP1A2CYP2A6TERT | |
| SCHEMBL18292168 | 0.80 | MAPT (0.45) | ACHECYP1A2CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3626339-A1 | RADICAL-GENERATING CATALYST, RADICAL PRODUCTION METHOD, OXIDATION REACTION PRODUCT PRODUCTION METHOD, CHEMICAL AGENT, AND CHEMICAL AGENT FOR AGRICULTURE AND LIVESTOCK | Acenet Inc. (JP) | 2020-03-25 | — | — | EP | claimed |
| EP-3391965-A1 | RADICAL GENERATING CATALYST, METHOD FOR PRODUCING RADICAL, METHOD FOR PRODUCING OXIDATION REACTION PRODUCT, DRUG, AND DRUG FOR AGRICULTURE AND LIVESTOCK | Acenet Inc. (JP) | 2018-10-24 | — | — | EP | claimed |
| EP-2479160-B1 | PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND | UNIV OSAKA (JP) | 2015-09-09 | — | — | EP | claimed |
| EP-2479160-A1 | PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND | Osaka University (JP) | 2012-07-25 | — | — | EP | claimed |
| US-20120171111-A1 | PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND | OSAKA UNIVERSITY (JP) | 2012-07-05 | — | — | US | claimed |
| US-12612415-B2 | Stereoselective process for preparing substituted polycyclic pyridone | SHIONOGI & CO., LTD. (JP) | 2026-04-28 | — | — | US | disclosed |
| EP-3693373-B1 | STEREOSELECTIVE PROCESS FOR PREPARING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES | SHIONOGI & CO (JP) | 2025-11-26 | — | — | EP | disclosed |
| EP-4599931-A1 | A DRUG COMPRISING A RADICAL GENERATING CATALYST | Acenet Inc. (JP) | 2025-08-13 | — | — | EP | disclosed |
| EP-4249494-B1 | A DRUG COMPRISING A RADICAL GENERATING CATALYST | ACENET INC (JP) | 2025-07-16 | — | — | EP | disclosed |
| US-20250129029-A1 | ACRIDINE COMPOUND | OSAKA UNIVERSITY (JP) | 2025-04-24 | — | — | US | disclosed |
| US-12281062-B2 | Light induced catalytic C—H oxygenation of alkanes | Ariel Scientific Innovations Ltd. (IL) | 2025-04-22 | — | — | US | disclosed |
| US-12096685-B2 | Persistent luminescence emitter | OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION (JP) | 2024-09-17 | — | — | US | disclosed |
| US-20120171111-A1 | PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND | OSAKA UNIVERSITY (JP) | 2012-07-05 | — | — | US | disclosed |
| US-7977486-B2 | Quinolinium ion derivatives, process for the production of the derivatives, products made by using the same, and reduction and oxidation methods with the derivatives | OSAKA UNIVERSITY (JP) | 2011-07-12 | — | — | US | disclosed |
| US-7977486-B2 | Quinolinium ion derivatives, process for the production of the derivatives, products made by using the same, and reduction and oxidation methods with the derivatives | OSAKA UNIVERSITY (JP) | 2011-07-12 | — | — | US | disclosed |
| WO-2011034071-A1 | PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND | 国立大学法人大阪大学 (JP) | 2011-03-24 | — | — | WO | disclosed |
| US-20100004454-A1 | QUINOLINIUM ION DERIVATIVES, PROCESS FOR THE PRODUCTION OF THE DERIVATIVES, PRODUCTS MADE BY USING THE SAME, AND REDUCTION AND OXIDATION METHODS WITH THE DERIVATIVES | OSAKA UNIVERSITY (JP) | 2010-01-07 | — | — | US | disclosed |
| US-20100004454-A1 | QUINOLINIUM ION DERIVATIVES, PROCESS FOR THE PRODUCTION OF THE DERIVATIVES, PRODUCTS MADE BY USING THE SAME, AND REDUCTION AND OXIDATION METHODS WITH THE DERIVATIVES | OSAKA UNIVERSITY (JP) | 2010-01-07 | — | — | US | disclosed |
| JP-2009078204-A | HYDROGEN GENERATION CATALYST | JAPAN SCIENCE & TECHNOLOGY AGENCY | 2009-04-16 | — | — | JP | disclosed |
| JP-2007308316-A | MANUFACTURE PROCESS OF HYDROGEN PEROXIDE | JAPAN SCIENCE & TECHNOLOGY AGENCY | 2007-11-29 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250129029-A1 | ACRIDINE COMPOUND | ACR, XDH, DRD4 | ACHE 2223/4885CYP1A2 127/4885CYP2A6 134/4885 |
| US-20120171111-A1 | PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND | TYR, AOX1, POR | ACHE 1014/4885CYP1A2 90/4885CYP2A6 427/4885 |
| US-12612415-B2 | Stereoselective process for preparing substituted polycyclic pyridone | POLR1A, RNASEH1, RNASEL | ACHE 1011/4885CYP1A2 834/4885CYP2A6 314/4885 |
| US-12281062-B2 | Light induced catalytic C—H oxygenation of alkanes | CBR1, CBR3, HAO2 | ACHE 2357/4885CYP1A2 51/4885CYP2A6 84/4885 |
| US-20100004454-A1 | QUINOLINIUM ION DERIVATIVES, PROCESS FOR THE PRODUCTION OF THE DERIVATIVES, PRODUCTS MADE BY USING THE SAME, AND REDUCTION AND OXIDATION METHODS WITH THE DERIVATIVES | APEX1, NQO1, POT1 | ACHE 1218/4885CYP1A2 2589/4885CYP2A6 4231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.